Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells
Krishnan K. Mahadevan, Kathleen M. McAndrews, Valerie S. LeBleu, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1606-1620.e8
Open Access | Times Cited: 99

Showing 26-50 of 99 citing articles:

Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer Therapy
Laura D'Alessio‐Sands, Joshua Gaynier, Victoria Michel‐Milian, et al.
Drug Development Research (2025) Vol. 86, Iss. 1
Closed Access
The Landmark Series: The Future of Pancreatic Cancer Clinical Trials
Yongwoo David Seo, Matthew H. G. Katz, Rebecca A. Snyder
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2777-2785
Closed Access
Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research (2025)
Open Access
Targeting secretory autophagy in solid cancers: mechanisms, immune regulation and clinical insights
Xinyu Li, Haiying Zhao
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Tendomodulin in pan-cancer analysis: exploring its impact on immune modulation and uncovering functional insights in colorectal cancer
Jingfeng Chen, Qin Hu, Cong Zhang, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
STAT3 Inhibition Prevents Adaptive Resistance and Augments NK Cell Cytotoxicity to KRASG12C Inhibitors in Nonsmall Cell Lung Cancer
Zehao Pan, Yuxian Qian, Yajing Wang, et al.
Cancer Science (2025)
Open Access
KRASG12D-driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC
Xiangyan Jiang, Tao Wang, Bin Zhao, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 2, pp. 101966-101966
Open Access
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development
Anne T. Schneider, Christiane Koppe, Émilie Crouchet, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
KRASG12D-Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients
Valerie S. LeBleu, Brandon G. Smaglo, Krishnan K. Mahadevan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer
Krishnan K. Mahadevan, Antonio Maldonado, Bingrui Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
ADT-1004: a first-in-class, oral pan-RAS inhibitor with robust antitumor activity in preclinical models of pancreatic ductal adenocarcinoma
Dhana Sekhar Reddy Bandi, Ganji Purnachandra Nagaraju, Sujith Sarvesh, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
The fibroinflammatory response in cancer
Zebin Xiao, Ellen Puré
Nature reviews. Cancer (2025)
Closed Access
Enhancing KRAS G12D inhibitor sensitivity in pancreatic cancer through SHP2/PI3K pathway
Miao Hao, Tian‐Xing Zhang, Dan Dong, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Drugging the Undruggable and beyond: Emerging precision oncology approaches to target acquired resistance to KRAS G12C and KRAS G12D inhibitors
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151688-151688
Closed Access
PRMT5 inhibitors: Therapeutic potential in pancreatic cancer
Carolin Schneider, Valentina Spielmann, Christian Braun, et al.
Translational Oncology (2025) Vol. 55, pp. 102366-102366
Closed Access
Exercise enhances cardiomyocyte mitochondrial homeostasis to alleviate left ventricular dysfunction in pressure overload induced remodelling
Zhichao Ma, Yanling Cen, Weiwei Xun, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pancreatic cancer
Thomas F. Stoop, Ammar A. Javed, Atsushi Oba, et al.
The Lancet (2025) Vol. 405, Iss. 10485, pp. 1182-1202
Closed Access
Hypoxia- and Lactate Metabolism-Associated Prognostic and Therapeutic Signature in Pancreatic Cancer
Chenhui Zhang, Anqi Huang, Cangchang Shi, et al.
Research Square (Research Square) (2025)
Closed Access
Road Map to Defeat Pancreatic Cancer
L. Paige Ferguson, David A. Tuveson
Annual Review of Cancer Biology (2025) Vol. 9, Iss. 1, pp. 1-20
Closed Access
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
R. Rosell, Jordi Codony‐Servat, Jessica González, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 195, pp. 104228-104228
Open Access | Times Cited: 12
Mutational signature and prognosis in adenocarcinoma of the bladder
Guoliang Yang, Akezhouli Shahatiaili, Shihao Bai, et al.
The Journal of Pathology (2024) Vol. 262, Iss. 3, pp. 334-346
Closed Access | Times Cited: 4
Inhibition of GTPase KRAS G12D : a review of patent literature
Yuhang Li, Le Yang, Xiaoran Li, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 8, pp. 701-721
Closed Access | Times Cited: 4
Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer
Yifan Fu, Jinxin Tao, Tao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Hope on the Horizon: A Revolution in KRAS Inhibition Is Creating a New Treatment Paradigm for Patients with Pancreatic Cancer
Andrew J. Aguirre, Ben Z. Stanger, Anirban Maitra
Cancer Research (2024) Vol. 84, Iss. 18, pp. 2950-2953
Closed Access | Times Cited: 4
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 4

Scroll to top